Showing results (131-140 of 151) with videos related to

Sort By:
Pageof 16
Nature Communications|December 2, 2022
Prior exposure to B. pertussis shapes the mucosal antibody response to acellular pertussis booster vaccinationEvi van Schuppen, Janeri Fröberg, Prashanna Balaji Venkatasubramanian, et al.
Trials|December 20, 2012
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trialGuy Thwaites, Cressida Auckland, Gavin Barlow, et al.
American Journal of Respiratory and Critical Care Medicine|January 17, 2019
Alveolar Macrophage Apoptosis-associated Bacterial Killing Helps Prevent Murine PneumoniaJulie A Preston, Martin A Bewley, Helen M Marriott, et al.
The Lancet. Microbe|December 4, 2025
Efficacy, immunogenicity, and safety of the live attenuated nasal pertussis vaccine, BPZE1, in the UK: a randomised, placebo-controlled, phase 2b trial using a controlled human infection model with virulent Bordetella pertussisDiane Gbesemete, Maheshi N Ramasamy, Muktar Ibrahim, et al.
Trials|August 2, 2020
ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trialTom Wilkinson, Rupert Dixon, Clive Page, et al.
The Lancet. Microbe|March 26, 2026
Safety, colonisation kinetics, transmissibility, and immune correlates of protection in healthy adults inoculated with Bordetella pertussis in England: a single-centre, open-label, phase 1, controlled human infection studyHans de Graaf, Diane F Gbesemete, Alison R Hill, et al.
Science Translational Medicine|July 8, 2021
A recombinant commensal bacteria elicits heterologous antigen-specific immune responses during pharyngeal carriageJay R Laver, Diane Gbesemete, Adam P Dale, et al.
Lancet (London, England)|September 25, 2021
Antibiotics for lower respiratory tract infection in children presenting in primary care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trialPaul Little, Nick A Francis, Beth Stuart, et al.
Health Technology Assessment (Winchester, England)|July 12, 2023
Antibiotics for lower respiratory tract infection in children presenting in primary care: ARTIC-PC RCTPaul Little, Nick A Francis, Beth Stuart, et al.
Lancet (London, England)|August 23, 2014
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trialRobert C Read, David Baxter, David R Chadwick, et al.
Pageof 16